127 related articles for article (PubMed ID: 38349229)
1. Molecular analysis of endobronchial ultrasound needle aspirates in patients with non-small cell lung cancer: Results from the SCOPE database.
Vakil E; Dumoulin E; Stollery D; Gillson AM; MacEachern P; Dhaliwal I; Mitchell M; Li P; Schieman C; Romatowski N; Chee AC; Tyan CC; Fortin M; Hergott CA; Tremblay A
Cytopathology; 2024 May; 35(3):378-382. PubMed ID: 38349229
[TBL] [Abstract][Full Text] [Related]
2. Endobronchial Ultrasound Guided Transbronchial Needle Aspiration and PD-L1 Yields.
Khoury LM; Sheehan KN; Mariencheck WI; Gershner KA; Maslonka M; Niehaus AG; Isom S; Bellinger CR
Lung; 2024 Jun; 202(3):325-330. PubMed ID: 38637361
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of endobronchial ultrasound-guided transbronchial needle aspiration for staging of non-small cell lung cancer.
Chung K; Bentel J; Laycock A
Diagn Cytopathol; 2024 May; 52(5):254-263. PubMed ID: 38348554
[TBL] [Abstract][Full Text] [Related]
4. EBUS in optimizing non-small cell lung cancer diagnosis and treatment.
Haranguş A; Berindan-Neagoe I; Toma L; Şimon I; Pop O; Şimon M
Med Pharm Rep; 2021 Apr; 94(2):176-184. PubMed ID: 34013188
[TBL] [Abstract][Full Text] [Related]
5. Endobronchial Ultrasound Guided Transbronchial Needle Aspiration and Next Generation Sequencing Yields.
Sheehan KN; Khoury LM; Niehaus AG; Mariencheck WI; Gershner KA; Dotson TL; Bellinger CR
Lung; 2024 Jun; 202(3):317-324. PubMed ID: 38687384
[TBL] [Abstract][Full Text] [Related]
6. Early experience of endobronchial ultrasound-guided transbronchial nodal cryobiopsy: a case series from Sabah, Malaysia.
Ramarmuty HY; Huan NC; Nyanti LE; Khoo TS; Renganathan T; Manoh AZ; Azman N; Sivaraman Kannan KK
Ther Adv Respir Dis; 2024; 18():17534666241231122. PubMed ID: 38357899
[TBL] [Abstract][Full Text] [Related]
7. Determining factors of endobronchial ultrasound-guided transbronchial needle aspiration specimens for lung cancer subtyping and molecular testing.
Zhang Y; Xie F; Mao X; Zheng X; Li Y; Zhu L; Sun J
Endosc Ultrasound; 2019; 8(6):404-411. PubMed ID: 31670289
[TBL] [Abstract][Full Text] [Related]
8. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration samples for programmed death ligand-1 testing in non-small cell lung cancer, the Bristol experience.
Hardy J; Bhatt N; Medford ARL
Asia Pac J Clin Oncol; 2022 Apr; 18(2):e32-e38. PubMed ID: 33870634
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Programmed Death Ligand-1 Immunohistochemical Staining Between Endobronchial Ultrasound Transbronchial Needle Aspiration and Resected Lung Cancer Specimens.
Sakata KK; Midthun DE; Mullon JJ; Kern RM; Nelson DR; Edell ES; Schiavo DN; Jett JR; Aubry MC
Chest; 2018 Oct; 154(4):827-837. PubMed ID: 30059678
[TBL] [Abstract][Full Text] [Related]
10. Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer.
Esterbrook G; Anathhanam S; Plant PK
Lung Cancer; 2013 Apr; 80(1):30-4. PubMed ID: 23312886
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience.
Karadzovska-Kotevska M; Brunnström H; Kosieradzki J; Ek L; Estberg C; Staaf J; Barath S; Planck M
PLoS One; 2022; 17(2):e0263342. PubMed ID: 35108331
[TBL] [Abstract][Full Text] [Related]
12. Adequacy of Samples Obtained by Endobronchial Ultrasound with Transbronchial Needle Aspiration for Molecular Analysis in Patients with Non-Small Cell Lung Cancer. Systematic Review and Meta-Analysis.
Labarca G; Folch E; Jantz M; Mehta HJ; Majid A; Fernandez-Bussy S
Ann Am Thorac Soc; 2018 Oct; 15(10):1205-1216. PubMed ID: 30011388
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of lung cancer biomarkers profile for the decision of targeted therapy in EBUS-TBNA cytological samples.
Gürün Kaya A; Çiledağ A; Erol S; Öz M; Doğan Mülazımoğlu D; Işık Ö; Özakıncı H; Çiftçi F; Şen E; Ceyhan K; Kaya A; Karnak D; Çelik G; İsmail S
Scott Med J; 2022 Feb; 67(1):18-27. PubMed ID: 35147461
[TBL] [Abstract][Full Text] [Related]
14. Adequacy of EBUS-TBNA specimen for mutation analysis of lung cancer.
Cicek T; Ozturk A; Yılmaz A; Aktas Z; Demirag F; Akyurek N
Clin Respir J; 2019 Feb; 13(2):92-97. PubMed ID: 30582673
[TBL] [Abstract][Full Text] [Related]
15. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients.
Navani N; Brown JM; Nankivell M; Woolhouse I; Harrison RN; Jeebun V; Munavvar M; Ng BJ; Rassl DM; Falzon M; Kocjan G; Rintoul RC; Nicholson AG; Janes SM
Am J Respir Crit Care Med; 2012 Jun; 185(12):1316-22. PubMed ID: 22505743
[TBL] [Abstract][Full Text] [Related]
16. Pilot Study of the Performance of 19-G Needle in Endobronchial Ultrasound-guided Transbronchial Aspiration for the Diagnosis and Testing of Molecular Markers in Lung Cancer.
Wahidi MM; Davidson K; Shofer S; Mahmood K; Cheng G; Giovacchini C; Jones C; Jug R; Pavlisko EN; Wang X; Gu L; Weimholt C; Zhou Z; Chen A
J Bronchology Interv Pulmonol; 2021 Jul; 28(3):209-214. PubMed ID: 33273249
[TBL] [Abstract][Full Text] [Related]
17. Suitability of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration versus Paired Transbronchial Biopsy Specimens for Evaluating Programmed Death Ligand-1 Expression in Stage III and IV Lung Cancer: A Comparative Retrospective Study.
Matsuoka H; Araya T; Kita T; Terada N; Yamamura K; Nishikawa S; Tambo Y; Sone T; Kimura H; Ooi A; Kasashima S; Kawashima A; Kasahara K
J Cancer; 2021; 12(15):4478-4487. PubMed ID: 34149911
[No Abstract] [Full Text] [Related]
18. Handling and standardization of EBUS needle aspiration in NSCLC patients: The value of the cell block, a monoinstitutional experience.
Parente P; Carbonelli C; Biancofiore G; Sukthi A; Di Micco CM; Vairo M; Fuso P; Taurchini M; Graziano P
Thorac Cancer; 2022 Sep; 13(17):2480-2488. PubMed ID: 35868633
[TBL] [Abstract][Full Text] [Related]
19. Clinical performance of endobronchial ultrasound-guided transbronchial needle aspiration for assessing programmed death ligand-1 expression in nonsmall cell lung cancer.
Biswas A; Leon ME; Drew P; Fernandez-Bussy S; Furtado LV; Jantz MA; Mehta HJ
Diagn Cytopathol; 2018 May; 46(5):378-383. PubMed ID: 29476608
[TBL] [Abstract][Full Text] [Related]
20. Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy.
Faber E; Grosu H; Sabir S; San Lucas FA; Barkoh BA; Bassett RL; Luthra R; Stewart J; Roy-Chowdhuri S
J Clin Pathol; 2022 Sep; 75(9):612-619. PubMed ID: 33952592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]